What is Diagnostics Direct?
Diagnostics Direct, LLC is an established provider of advanced CLIA Waived Sexually Transmitted Disease (STD) diagnostic tests. The company's offerings are characterized by ease of administration, straightforward interpretation, and high accuracy, enabling faster patient treatment and management. Their focus on cutting-edge diagnostic solutions positions them as a key player in the point-of-care testing sector.
How much funding has Diagnostics Direct raised?
Diagnostics Direct has raised a total of $65K across 1 funding round:
Debt
$65K
Debt (2021): $65K with participation from PPP
Key Investors in Diagnostics Direct
PPP
Public-Private Partnership
What's next for Diagnostics Direct?
With the recent influx of substantial expansion capital, Diagnostics Direct is poised for accelerated growth and market penetration. The company is expected to leverage this financing to scale its operations, enhance its product development pipeline, and potentially expand its geographic reach. Strategic investments in technology and distribution channels will likely be key priorities as Diagnostics Direct aims to solidify its leadership in the diagnostic testing industry.
See full Diagnostics Direct company page
